Neurology News

• AAN 2025 Novel Agent for AD Agitation Continues to Show Promise Continued treatment with AXS-05, a combination of dextromethorphan and bupropion, significantly reduces the risk for recurrence of Alzheimer’s disease–related agitation, phase 3 results show.
  Medscape Medical News, April 11, 2025
• ACP-IM 2025 Eye-Opening Updates in Insomnia and OSA Expert shares treatment approaches for insomnia and alternatives for patients With PAP-intolerance.
  Medscape Medical News, April 11, 2025
• AAN 2025 Prenatal Folic Acid May Boost Brain Health in Offspring Taking folic acid early in pregnancy is safe, even at high doses, and associated with improved neuropsychological outcomes in the offspring at age 6 years.
  Medscape Medical News, April 11, 2025
• NICE Urges Reform of ‘Inconsistent’ Neuro Rehab Services Draft guidance addresses ‘widespread’ disparities in neurological rehabilitation in England and urged better coordination and holistic patient care.
  Medscape News UK, April 10, 2025
• AAN 2025 AI-Powered Wearable Calms Essential Tremor The Felix NeuroAI wristband delivers tailored and dynamic electrical stimulation to the ulnar, median, and radial nerves throughout the day to relieve essential tremor.
  Medscape Medical News, April 10, 2025
• AAN 2025 Inebilizumab Effective Up to 52 Weeks in Myasthenia Gravis Inebilizumab, a first-in-class CD19+ B-cell–targeting agent, is safe and effective for up to 1 year in patients with generalized myasthenia gravis, a phase 3 trial suggests.
  Medscape Medical News, April 10, 2025
• ACC 2025 Rivaroxaban Comparable to Warfarin for LV Thrombus Post-MI The direct oral anticoagulant is an effective alternative to warfarin that offers predictable dosing without the need for routine monitoring in patients with STEMI, the RIVAWAR trial shows.
  Medscape Medical News, April 10, 2025
• AAN 2025 First-in-Class Digital Therapeutic Effective for Migraine Adding an investigational prescription digital therapeutic to standard medication is linked to fewer migraine days than an add-on digital sham, a new phase 3 trial suggests.
  Medscape Medical News, April 09, 2025
• ACC 2025 So Far, TAVI Device for Aortic Regurgitation Is Effective A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used off-label for the treatment of aortic regurgitation.
  Medscape Medical News, April 09, 2025
• Experts Push Back on RFK Jr’s Infection Comments The new Secretary of Health and Human Services has made claims about measles and other communicable diseases that could lead to sickness, and even death, his critics claim.
  Medscape Medical News, April 09, 2025
• Survival After Sudden Cardiac Arrest Rises in Young Athletes Among young competitive athletes in the United States, survival after sudden cardiac arrest has improved over time, but racial disparities persist and warrant emergency preparedness.
  Medscape Medical News, April 09, 2025
• Concerns Raised Over DTC Platform for Alzheimer’s Diagnosis Some neurologists and a consumer watchdog worry that an Eli Lilly–affiliated direct-to-consumer telehealth platform for Alzheimer’s could lead to misdiagnosis or unnecessary treatment.
  Medscape Medical News, April 09, 2025
• Magnetic Brain Stimulation Shows Promise in Alzheimer's Care Personalised magnetic stimulation of the precuneus over 52 weeks slows cognitive and functional decline compared with sham in mild to moderate Alzheimer's, a trial shows.
  Medscape News UK, April 09, 2025
• When a ‘Difficult’ Patient Dies Unexpectedly This difficult patient pushes clinical staff to their limits — but his quiet, unnoticed decline exposes critical issues in communication, compassion, and care.
  Medscape Medical News, April 09, 2025
• Novel Blood Test Could Help Diagnose, Track Alzheimer’s A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of the disease more accessible in clinical practice.
  Medscape Medical News, April 09, 2025
• ACC 2025 Novel Drug Moving Forward for Lp(a) A single dose of an siRNA molecule reduces elevated lipoprotein(a) — a major, but to date, largely untreatable risk factor for cardiovascular disease — a phase 2 trial shows.
  Medscape Medical News, April 08, 2025
• More Evidence Ties Diabetes Meds to Lower Dementia Risk GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a neuroprotective effect.
  Medscape Medical News, April 08, 2025
• AAN 2025 Transnasal Cooling Promising for Migraine Delivering room-temperature air through the nose to cool the sphenopalatine ganglion taps into a powerful neuromodulatory pathway to relieve acute migraine pain, early data showed.
  Medscape Medical News, April 08, 2025
• AAN 2025 Frequent Nightmares Linked to Faster Aging, Premature Death Frequent distressing dreams are linked to faster biologic aging and an increased risk for premature death, independent of traditional risk factors, new research suggests.
  Medscape Medical News, April 08, 2025
• Treating Fibromyalgia With rTMS May Improve Pain, Function Noninvasive brain stimulation can reduce the burden of fibromyalgia, but questions remain about which patients can benefit.
  Medscape Medical News, April 08, 2025